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Background. The molecular mechanisms of the immune response after polytrauma are highly complex and far from fully
understood.Inthispaper,wecharacterizeanewstandardizedpolytraumamodelinratsbasedontheearlymolecularinﬂammatory
and apoptotic response. Methods. Male Wistar rats (250g, 6–10/group) were anesthetized and exposed to chest trauma (ChT),
closed head injury (CHI), or Tib/Fib fracture including a soft tissue trauma (Fx+STT) or to the following combination of
injuries: (1) ChT; (2) ChT+Fx+STT; (3) ChT+CHI; (4) CHI; (5) polytrauma (PT=ChT+CHI+Fx+STT).Sham-operated
ratsservedasnegativecontrols.Theinﬂammatoryresponsewas quantiﬁedat2hoursand4hoursaftertraumabyanalysisof“key”
inﬂammatory mediators, including selected cytokines and complement components, in serum and bronchoalveolar (BAL) ﬂuid
samples. Results. Polytraumatized (PT) rats showed a signiﬁcant systemic and intrapulmonary release of cytokines, chemokines,
and complement anaphylatoxins, compared to rats with isolated injuries or selected combinations of injuries. Conclusion. This
new rat model appears to closely mimic the early immunological response of polytrauma observed in humans and may provide a
validbasisfor evaluation ofthecomplex pathophysiology andfuturetherapeutic immunemodulatoryapproaches in experimental
polytrauma.
1.Introduction
Trauma is still one of the leading causes of death among
people aged 45 and younger. The annual economic burden
of direct and indirect costs in Germany alone is estimated
to be around 40 billion Euros annually [1]. Due to the
heterogeneity of trauma, complex injury patterns, and broad
variabilityoftherapeuticoptions,itisanenormouschallenge
to collect valid data in prospective or retrospective studies
concerning posttraumatic pathophysiological changes and
possible treatment options.
Of all polytraumatized patients 86% sustain an injury to
the extremities, 69% to the head, and 62% to the chest [2].
In this regard, the eﬀects of a combined injury on the patient
are not comparable to that after isolated trauma. Trupka et
al. indicated that mortality rises from 7% to 18% when an
additional trauma to the chest is present. Musculoskeletal
trauma induces the systemic release of diverse “danger
molecules” DAMPs (danger-associated molecular patterns)
[3] which lead to a pronounced early immunological and
inﬂammatory response [4]. The release of these DAMPs
is a tremendous challenge for the immune system in2 Mediators of Inﬂammation
severe trauma as explained by the “danger model” of the
immune system (danger sensing, transmission, response,
elimination) [3, 5]. As a consequence of the injury severity
and the immune status of the patients, the posttraumatic
inﬂammatory response often results in an overindulging and
uncontrolled activation of the complement system with an
increased release of proinﬂammatory mediators [6]o f t e n
resulting in multiple organ dysfunction and death. In this
regard, IL-6 has been shown to be elevated at the scene
of injury and a positive correlation between these IL-6
levels, the severity of the injury and the increased rate
of complications including enhanced mortality has been
demonstrated [7, 8]. In addition, increased systemic levels of
the anaphylatoxins C3a and C5a in severe polytraumatized
patients seem to be correlated with a higher risk of sepsis
and a poor clinical outcome [6, 9]. However, up to date,
little is still known about the immune response after severe
polytrauma on a cellular and molecular basis. In particular,
it is still unclear whether the early immune response is
qualitatively or quantitatively diﬀerent after severe poly-
trauma compared to an isolated injury. Furthermore, there
is a lack of pathophysiology-based therapeutic remedies
for polytrauma patients to prevent posttraumatic immuno-
suppression. Therefore, highly standardized experimental
polytrauma models are required to deﬁne the early complex
pathophysiology of severe combined trauma and to examine
novel surgical or immunomodulatory treatment options.
Inthisstudy,wedescribeanewpolytraumamodelinrats
and characterize the early systemic and local inﬂammatory
response accompanied by a rapid activation of the comple-
ment system similar to that seen in humans.
2.MaterialsandMethods
2.1. Animals and Anesthesia. The study protocol was ap-
proved by the University Animal Care Committee and
the federal authorities for animal research, Tuebingen,
Germany. The experiments were performed in adherence
to the National Institutes of Health Guidelines for the use
of laboratory animals including a total of 352 male Wistar
rats (250g, 10–12 weeks, Jackson Laboratories, Bar Har-
bour). Anaesthesia was applied i.p. using 75mg/kg Ketamin
(Ketavet,PﬁzerPharma,Karlsruhe,Germany)and0.4mg/kg
KG Medetomidine i.p. (Dormitor, Pﬁzer Pharma, Karlsruhe,
Germany). Animals which underwent blunt chest trauma
were anesthetized with a mixture of 4% sevoﬂurane (Sevo-
rane Abbott, Wiesbaden, Germany) and 96% oxygen under a
continuous ﬂow of 2L/min and received the aforementioned
i.p anesthesia after the chest trauma.
2.2. Individual Trauma Models. T h er a t sw e r er a n d o m l y
assigned to the diﬀerent trauma groups (each n = 6–10).
Narcotized rats underwent either a Sham operation (Sham),
a blunt bilateral chest trauma (ChT), a blunt bilateral chest
trauma and a lower leg (tibia/ﬁbula) fracture with a contra-
lateral soft tissue trauma (ChT + Fx + STT), a closed head
injury(CHI),abilateralbluntchesttraumaandaheadinjury
(ChT+CHI),oracombinationofchesttrauma,headtrauma,
fracture, and soft tissue trauma referred to as polytrauma
(PT). Sham animals were anesthetized rats with an incision
and surgical closure of the aponeurotic galea. All animals
were placed on a heating pad after undergoing the surgical
procedures. Continuous reﬂex status and vital signs of all
animals were checked.
Animals subjected to the blunt bilateral chest trauma
were narcotized and ﬁxed in a supine position. The trauma
was induced by a single blast wave as previously described
[10–12]. The traumatic brain injury was induced by a
weight drop device inducing a focused blunt injury over an
intact skull after 1.5cm incision of the aponeurotic galea
as described in detail elsewhere [13, 14]. After trauma, the
incision was closed by a monoﬁl suture. For the right side
tibia/ﬁbula fracture a weight drop device (650g, 13cm)
induced a reproducible closed transverse fracture of the
lower leg, as reported in the past [15]. On the contra-
lateral gastrocnemic region a soft tissue injury was applied
using a weight drop device (170g, 180cm) as previously
described [16]. Vital signs were documented during the
whole experiment and blood gas analysis was performed.
Waking the animals after trauma was strictly avoided and
anaesthesia was deepened with repeated i.p. injections as
necessary . After 2hrs or 4hrs, respectively , all rats were
sacriﬁced and the blood and organs harvested.
2.3. Blood-, Lung-, and BAL-Fluid Preparation. Whole blood
was spun at 500×ga t4 ◦C for 10min, the serum stored
at −80◦C until ﬁnal analysis. After death the trachea was
dissected and cannulated, the left lung clamped, and the
right lung ﬂushed 3 times with 5mL PBS including 1:1000
broadspectrumproteaseinhibitor(Sigma-Aldrich,St.Louis,
MO, USA). The BAL ﬂuids were then centrifuged 450×ga t
(4◦C) for 10min and stored at (−80◦C) until analysis. Left
lung tissue was ﬁlled with formalin after BAL was taken and
immediately stored in 10% formalin until evaluation.
2.4. Cytokine ELISA. Interleukin (IL)-6, tumor necrosis
factor(TNF)-α,complementanaphylatoxin3a(C3a),mono-
cyte chemoattractant protein (MCP)-1 (all BD OptEIA
ELISA SET, BD Pharmingen, San Diego, CA), and cytokine-
induced neutrophil chemoattractant (CINC) (R&D, Min-
neapolis, MN, USA) concentrations of BAL-ﬂuids were
determined by sandwich-enzyme-linked immunosorbent
assay technique (ELISA) according to the manufacturer’s
recommendation. In serum, IL-6, TNF-α, and CINC were
detected.
2.5. Serum Complement Hemolytic Activity (CH 50). The
activity of the complement system was assessed by CH50
measurements. A dilution series of the samples was made
(1/20–1/480) using Tris-buﬀered saline (TBS) and the
diluted samples were incubated for 60min at 37◦Cw i t h
sheep erythrocytes (Colorado Serum Company, Denver,
CO, USA). The hemolytic complement system reaction was
stopped using ice-cold TBS and centrifugation at 700×gf o r
5min. The absorption of the supernatant was measured at
541nm by spectrophotometry.Mediators of Inﬂammation 3
2.6. Flow Cytometry Analysis. EDTA whole blood (100μL)
was incubated with indicated FITC- or PE-labelled ﬂu-
orochrome-conjugated monoclonal antibodies at room tem-
perature for 20min in the dark. Immediately after the incu-
bationperiod,2mLofFACSlysingsolution(BDBiosciences)
was added to each tube, followed by incubation for 10min
at room temperature in the dark. The tubes were then
centrifuged for 5min at 340×g. After centrifugation, the
supernatant was removed, and 2mL of Dulbecco phosphate-
buﬀered saline (DPBS) per tube was added, followed by
an additional centrifugation step. After a second washing
step, the cell pellet was resuspended in 100μLo fC e l l F I X
Solution (BD Biosciences) for ﬁnal ﬂow cytometric analysis.
Leukocyte populations (neutrophils, monocytes, and lym-
phocytes) were discriminated by forward/sideward scatter
and additional CD45 staining. For each measurement, a
minimum of 10,000 events was analyzed. For quantiﬁcation
of C3aR and CRegs (CD35, CD55, and CD59) expression,
mean ﬂuorescence intensity (MFI) emitted by the FITC- or
PE-conjugated antibodies was calculated by subtracting the
corresponding isotype control.
2.7. Histological Evaluation. Formalin-ﬁxed lung tissue was
dehydrated using ethanol, dissolved with Xylol and embed-
ded in paraﬃn. Sections of 1μm were prepared followed by
H&E staining. Following that a semiquantitative analysis of
the sections including a cell count was performed.
2.8. Preparation of PMNs. Whole blood of rats was drawn
from the portal vein. Blood was transferred into syringes
containing EDTA. Polymorphonuclear neutrophils (PMNs)
were isolated using Ficoll-Paque (Pharmacia Biotech, Stock-
holm, Sweden) gradient centrifugation (340×g, 30min,
room temperature). The use of this technique may be
responsible for some artiﬁcial activation of cells in vivo
[17]. For neutrophil isolation, red blood cells (RBCs) were
sedimented with dextran and residual RBCs were removed
by hypotonic lysis. Neutrophils were resuspended in DPBS
and ﬁnally diluted at 2Mio cells per mL. 1mL aliquots
of PMNs were centrifuged at 800g for 5min, supernatants
were removed, and cells were resuspended in 100μLo f
Pharmigen Cell Lysis Buﬀer (BD Biosciences). After 30min
ofincubationonice,sampleswerepelleted(16000×g,5min,
4◦C) and supernatants were frozen at −80◦C.
2.9. Statistics. Results are presented as mean ± SD. A one-
way analysis of variance (ANOVA) followed by the Student-
Newman-Keuls test as a post hoc test for multiple com-
parisons was performed to determine signiﬁcant diﬀerences
between experimental means. A P v a l u eo fl e s st h a n0 . 0 5w a s
considered statistically signiﬁcant.
3. Results
3.1. Hematologic Findings. The blood gas analysis (2 and
4hrs after injury) was indicative of stable Hemoglobin (Hb)
and Hematocrit (Hct) values in this polytrauma model. The
HbvaluesdidnotsigniﬁcantlydiﬀerinShamandPTanimals
(Sham 2h 16.5 ± 0.4g/dL versus PT 2h 16.2 ± 0.4g/dL
Sham 4h 16.5 ± 0.32g/dL versus PT 4h 15.4 ± 0.4g/dL; data
not shown). The pO2 levels stated no hypoxic state in the
anaesthetizedanimals(Sham4h87.7 ±2.0mmHgversusPT
4h 90.0 ± 3.6mmHg, data not shown).
3.2. Systemic Inﬂammatory Response following Trauma. As
early as 2hrs after injury, systemic IL-6 levels were not
signiﬁcantly increased in PT animals compared to the
sham group. However, 4hrs after polytrauma there was a
signiﬁcant increase in the IL-6 concentrations (Figure 1(a)).
Similarly, CINC serum concentrations were signiﬁcantly
enhanced in ChT + Fx + STT, ChT + CHI, and PT groups
compared to the Sham group 4hrs after injury (Figure 1(b)).
Systemic TNF-α levels were rather unchanged in all groups
up to 4hr after injury (Figure 1(c)).
3.3. Local Inﬂammatory Response following Trauma. In ad-
dition to the systemic inﬂammatory response, the local
inﬂammatory changes were investigated with focus on the
lungs. The local concentrations of IL-6 in the BAL ﬂuids
were increased in PT, ChT + CHI and ChT rats 4hrs after
injury compared to Sham-treated rats (Figure 2(a)). Four
hours after trauma, the local TNF-α levels were increased in
all trauma groups except CHI alone (Figure 2(b)). CINC and
MCP-1 levels in BAL-ﬂuids were signiﬁcantly increased in all
groupscomparedtoShamandCHIanimals4hrsafterinjury
(Figures 2(c) and 2(d)).
3.4. Histological Changes in Lung Tissues after Trauma.
Early morphological changes were assessed on H&E stained
lung tissue sections analyzed with 20x magniﬁcation. Lung
sections of the control animals showed physiological lung
parenchyma identical to the morphology seen in the trau-
matic brain injury (CHI) group. After bilateral blunt chest
trauma plentiful erythrocytes could be found intra-alveolar,
intra-bronchial and sub-pleural. In addition an increased
number of alveolar macrophages, some damage to the
alveolarwallandtissueedemawerefound.Similarqualitative
morphological changes could be detected in PT-animals but
all in a markedly aggravated intensity (Figure 3).
3.5. Complement Response after Trauma. The trauma-in-
duced changes of the complement system were ﬁrst screened
by CH50 testing (Figure 4(a)). After 2hrs there was a min-
imum decrease in CH50 values in the PT-group compared
to the Sham group, but after 4hrs this diﬀerence reached
statistically signiﬁcance, indicating systemic complement
activation. Focusing on the central complement activation
product C3a, BAL-ﬂuid levels of C3a were signiﬁcantly
increased in PT animals compared to Sham animals 4hrs
after trauma (Figure 4(b)). The related C3aR revealed a
signiﬁcant loss of surface expression on neutrophils iso-
lated 4hrs after polytrauma, whereas the C3aR proﬁle
remained rather unchanged on monocytes and lymphocytes
(Figure 4(c)). Protectin, also known as CD59, exhibited no
diﬀerence in the expression on neutrophils after trauma
(Figure 5). In contrast, complement receptor 1 (CD35) was4 Mediators of Inﬂammation
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Figure 1: Systemic inﬂammatory response following trauma, (a) shows the systemic IL-6 (pg/mL) serum levels in Sham versus PT animals 2
and 4hrs after trauma, (b) the CINC (pg/mL) serum concentrations in Sham versus PT animals 2 and 4hrs after trauma and (c) the TNF-α
(pg/mL) serum levels in Sham versus PT animals 2 and 4hrs after trauma. All data are presented as mean ± SD. ∗P<0.05. n = 6–10
rats/group.
signiﬁcantly decreased in PT animals versus Sham rats
(Figure 5).Aslightbutinsigniﬁcantdecreaseinexpressionof
CD55couldbedetectedonneutrophilsinPT-rats(Figure 5).
4. Discussion
The clinical and molecular danger management after poly-
trauma is rather complex and often associated with fatal
complications. However, the resulting immune and inﬂam-
matory response is still in the dark. The aim of this study
was to establish a highly standardized and reproducible
rodent polytrauma model capable of closely mimicking the
posttraumatic inﬂammatory response found in humans.
Patients at the scene are dying mostly based on severe
brain injury or massive blood loss following an injury
to a large blood vessel. In contrast, mortality of patients
in the hospital several days after major trauma is often
associated with a severe systemic inﬂammatory response
(SIRS) and resulting systemic changes such as coagulopathy
and complementopathy, breakdown of physiological barri-
ers, impairment of the immune defense, and ﬁnally organ
dysfunction and failure [6]. The proinﬂammatory cytokines
(e.g., IL-6, IL-8, etc.) and complement anaphylatoxins (e.g.,
C3a, C5a) were experimentally and clinically proposed to
be crucially involved in the early damage response after
severe trauma and somehow indicative of the degree of
tissue damage and clinical outcome [6, 9]. In the cecalMediators of Inﬂammation 5
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Figure 2: Local inﬂammatory response following trauma, (a) shows IL-6 (ng/mL) BAL-Fluid levels in Sham-, ChT-, ChT+Fx+STT-, ChT+
C H I - ,C H I -a n dP T - r a t s4h r sa f t e rt r a u m a ,( b )T N F - α (ng/mL) BAL-Fluid levels in Sham-, ChT-, ChT+Fx+STT-, ChT+CHI-, CHI- and
PT-rats 4hrs post trauma, (c) CINC (pg/mL) BAL-Fluid concentrations in Sham-, ChT-, ChT + Fx + STT-, ChT + CHI-, CHI- and PT-rats
4hrs after trauma and (d) MCP-1 BAL-Fluid levels in Sham-, ChT-, ChT+Fx+STT-, ChT+CHI-, CHI- and PT-rats 4hrs after trauma. All
data are presented as mean ± SD. ∗P<0.05 to Sham; #P<0.05 signiﬁcant to CHT. n = 6–10 rats/group.
ligation and puncture (CLP) sepsis model in rodents, the
complement activation product C5a has been shown to
contribute signiﬁcantly to the development and progres-
sion of the systemic inﬂammatory response. Furthermore,
blockade of the C5a-C5aR interaction was associated with
improved function on a molecular, cellular, and organ-
level and ﬁnally resulted in a beneﬁcial outcome [18–20].
However, it is rather unclear if a similar immune modulation
would provide some advantageous eﬀects in the setting of
multiple injuries. This needs to be investigated further using
this new polytrauma model. In the context of the complexity
of the polytrauma danger response and the lack of eﬀective
therapeutics in the early posttraumatic phase, it is somehow
surprising, that despite highly eﬀective anaesthesia protocols
there is a worldwide lack of valid rodent models closely
simulating multiple injuries of humans. The present blunt
trauma model was designed to combine clinically important
injury patterns. The single traumata used has been well
established and are highly standardized and reproducible
in rodents [11–13, 15, 21, 22]. Upon adjustment to the
combined injury application, this model provides the unique
opportunity to study the impact of an individual trauma
anddiﬀerenttraumacombinationsonthefollowingimmune
response. A lethality of up to 20% could be detected in6 Mediators of Inﬂammation
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Figure 3: Histological changes in lung tissues after trauma, H&E stained lung tissue sections of Sham-, ChT-, CHI and PT-rats analysed by
light microscopy with 20x ampliﬁcation.
this model which reﬂects the lethality of polytraumatized
humans(annualreportoftheGermantraumaregister2009).
Care has been taken to ﬁrst design a hemodynamically
stable polytrauma model to rule out hemorrhagic shock
eﬀects on the inﬂammatory response. According to Sauaia
et al. hemorrhage following traumatic injury accounts for
30–40% of deaths [23]. This could be excluded by BGA
measurements showing stable haemoglobin and hematocrit
values. However, hemorrhage/shock as well as abdominal
trauma certainly represents certainly a major trigger of
the inﬂammatory response [24]. Thus, pressure-controlled
hemorrhage or CLP may be included in this model in
future studies to discriminate their contribution to the
inﬂammatory response as well.
The early systemic inﬂammatory response in the present
multiple injury model was reﬂected by enhanced serum
levels of IL-6 and CINC which are also enhanced in
polytrauma patients [25, 26] and somehow associated with
the injury severity and predictive of the clinical outcome. In
comparison to Sham-treated animals, the systemic TNF-α
levels of PT littermates were rather unchanged in the early
posttraumatic phase. In contrast, TNF-α levels in multiply
injured patients were found to be increased early after
trauma [27] but rather irrelevant for the prediction of injury
severity or outcome. In ex vivo experiments, even a decrease
in TNF-α levels in stimulated whole-blood samples from
polytraumatized patients 2–4hrs after trauma was reported
in relation to healthy donor samples [28].
The local inﬂammatory polytrauma response with focus
on the lungs as “the engine of multi-organ dysfunction”
[2] was reﬂected by increased concentrations in BAL ﬂuids
of cytokines and chemokines early after trauma. Similar
chemokine proﬁles have been reported for blunt chest
trauma alone by our group [29]. In the clinical setting
of blunt chest trauma, there is a lack of data in BAL-
ﬂuids [30] but a distinct increase of these cytokines in
whole blood with an overall correlation with lung injury
severity [8, 26]. Present histological analysis of polytrau-
matized rats revealed severe intra-alveolar, intrabronchial,
a n ds u b p l e u r a lh e m o r r h a g ea sw e l la st h ep r e s e n c eo f
interstitial oedema, atelectasis, and an increased amount of
alveolar macrophages. These changes have been described
in experimental blunt chest trauma alone [22], but in PT
animals an aggravation of the histological alterations is
evident. The pathophysiological reasons for this enhanced
lung injury are rather speculative and might be due to
the accompanied brain injury with subsequent disturbances
of the neurohormonal-stress-inﬂammation axis or due to
a speciﬁc mediator release by the fracture. Fremont et al.
described that polytraumatized patients with systemically
increased plasma levels of TNF-α, IL-8, or IL-10 are more
likely to develop ARDS [31].
The complement response globally screened by CH50
changeswasunalteredearlyafterpolytrauma.However,4hrs
after multiple injuries, a decent but signiﬁcant decrease in
CH50wasobserved.Itisnoteworthythatalreadyareduction
in CH50 by 10% can be considered as evidence of signif-
icant systemic complement activation. These ﬁndings are
supported by recent reports showing complement activation
after major trauma in humans [32].Mediators of Inﬂammation 7
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Figure 4: Systemic complement response after trauma, (a) presents the hemolytic activity (CH50/mg) on Sham- and PT-rats 2 and 4hrs
after trauma, (b) the C3a (ng/mL) BAL-Fluid levels in Sham- versus PT-rats 2 and 4hrs post trauma and (c) the C3aR Expression (MFI)
on Monocytes, Neutrophils and Lymphocytes in Sham- and PT-rats 4hrs after trauma. All data are presented as mean ± SD. ∗P<0.05.
n = 6–10 rats/group.
Complement regulation after severe tissue trauma has
been recently addressed by our group, describing a speciﬁc
leukocyte expression proﬁle of the complement regulatory
proteins (CRegs) CD55, CD59, and CD35 early after poly-
trauma. Whereas CD59 and CD55 were rather unchanged,
CD35 expression on neutrophils in the PT versus Sham-
group was signiﬁcantly reduced. The dynamic of CReg
expression beyond the 4hr observational period remains to
be seen. However, based on the extremely heterogenous
patient groups and the complexity of the pathophysio-
logical reaction, the apoptotic response has been reported
rather controversially in polytrauma patients [33, 34]. Guo
et al. described during sepsis induced by CLP a C5a-
induced decrease of the neutrophil apoptosis rate along
with increased levels of Bcl-XL and decreased levels of Bim
[35]. Addressing the posttraumatic regulation of the reduced
neutrophilapoptosis ratefurthermechanisticstudiesneedto
be performed in the present novel polytrauma model.
The present study has some limitations. During the short
observation period, 4hrs maximum according to the Animal
Care Committee protocol, after injury the organisms may
be incapable to building up the full inﬂammatory response
especially in the absence of shock symptoms. In addition,
the applied traumata and early posttrauma phase occurred
in deep anaesthesia, which certainly exclude an additional
stress-load seen in reality. On a technical level, although
performed within 7min, the traumata could not be applied
simultaneously as it usually occurs in reality.
The role of each single trauma on the pathophysiology
of polytrauma leading to SIRS, Sepsis, and MOF is still
unknown. However, each isolated injury is survivable, the
combination may become lethal. The patient’s prognosis8 Mediators of Inﬂammation
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Figure 5: Complement regulatory response after trauma, CReg
Expression (MFI) CD59, CD35 and CD55 on neutrophils (PMNs)
in Sham- and PT rats 4hrs after trauma. All data are presented as
mean ± SD. ∗P<0.05. n = 6–10 rats/group.
and the outcome mainly depends on the presence of the
traumatic brain injury and the associated secondary brain
damage [36].
In summary, this study is—to our knowledge—the ﬁrst
to demonstrate very early inﬂammatory changes in a highly
standardized, reproducible, hemodynamically stable poly-
trauma rodent model, mimicking most important injuries
of polytraumatized patients excluding hemorrhagic shock.
The present polytrauma model may therefore represent
the basis for further investigation of the pathophysiology
of polytrauma and the evaluation of early therapeutic
interventions.
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